Gilead Must Face Whistleblower Lawsuit Over Alleged Sovaldi and Harvoni Kickback Scheme
A whistleblower lawsuit against Gilead can proceed with allegations the company was engaged in illegal Solvaldi and Harvoni kickback schemes.
A whistleblower lawsuit against Gilead can proceed with allegations the company was engaged in illegal Solvaldi and Harvoni kickback schemes.
A new report warns that some hepatitis C drugs may cause severe liver injury and liver failure, sometimes because they can reactivate the hepatitis B virus.
European medical regulators warn that some hepatitis C drug side effects could reactivate dormant hepatitis B viral infections in patients, causing liver damage and potentially death.
Gilead is warning that its hepatitis C drugs, Harvoni and Sovaldi may increase the risk of heart rhythm problems and death in patients also taking the heart drug amiodarone.
A new report highlights weaknesses in the FDA's adverse reporting system due to incomplete manufacturer reports.